News Now

Amgen and AstraZeneca Present Groundbreaking Oncology Data at ESMO, Demonstrating a 58% Reduction in Risk of Death for Small Cell Lung Cancer

Amgen and AstraZeneca presented practice-changing Phase 3 clinical data at the European Society for Medical Oncology (ESMO) 2026 Congress, demonstrating that frontline maintenance therapy combining Imdelltra (tarlatamab-dlle)and Imfinzi (durvalumab) cut the risk of...

​Next-Generation MAKO 4 Robotic-Assisted Surgery System Officially Launched to Advance Precision in Joint Replacement

In a major development for orthopedic surgical technology, medical device innovators and surgical teams have celebrated the official rollout of...

​Indian Pharmacopoeia Commission Issues Drug Safety Alert Linking Levetiracetam and Topical Decongestants to Specific Adverse Reactions

The Indian Pharmacopoeia Commission (IPC), functioning as the National Coordination Centre for the Pharmacovigilance Programme of India (NCC-PvPI)...

Rising Yields Hit Sun Pharma’s Fundraising Drive as Bond Issue Misses ₹10,000 Crore Goal

India’s largest drugmaker by market capitalisation Sun Pharmaceutical Industries has raised ₹7,816 crore (~8000 cr) against its ₹10,000-crore fundraising target, highlighting the growing...

GLP-1 Boom: China, India and Brazil Could Unlock a $22 Billion Market by 2035 , J.P. Morgan Estimates

The market for GLP-1 medicines across China, India and Brazil could surge from $6.6 billion currently to $22 billion...

AbbVie Announces FDA Approval of JUVMO™️ for Adults with Parkinson’s Disease

Food and Drug Administration (FDA) for JUVMO™ (tavapadon) to treat adult patients living with Parkinson’s disease. JUVMO represents a first-of-its-kind therapeutic approach, utilizing a...

Sun Pharma and LIB Therapeutics Announce Global Licensing Agreement for Novel PCSK9 Inhibitor Lerodalcibep

​ Sun Pharmaceutical Industries Limited and LIB Therapeutics Inc.  announced an exclusive global licensing, manufacturing, and commercialization agreement for lerodalcibep across international markets, excluding the United...

Empowering Pharmaceutical Innovation: Bharat Technology Wraps up a Stellar BT-PHARMACON 2k26

Bharat Technology's national conference, BT-PHARMACON 2K26, was held bringing together eminent personalities from the State Government, the Pharmacy Council of India (PCI), academia, and...

Johnson & Johnson Announces 69.2% Five-Year Overall Survival Rate for CARVYKTI in CARTITUDE-2 Study

​At the five-year evaluation mark, half of the treated patients (50%) remained alive and progression-free. The trial demonstrated a notable five-year overall survival rate...

KMC Food Safety Officials and Kolkata Police Conduct Early-Morning Milk Surveillance Drive at Baithakhana Market

In an active push to protect consumer health and enforce regulatory compliance across the city’s dairy supply chain, the Food Safety Team of the...

PCI President Dr. Montu M. Patel Calls for 10 Industry MoUs & Rural Healthcare Engagement at BT-PHARMACON 2K26

Addressing BT-PHARMACON 2K26, organized by Bharat Technology at EZCC, Kolkata, Pharmacy Council of India (PCI) President Dr. Montu M. Patel emphasized the need for...